CID 11539025

Ralimetinib

Structural Information

Molecular Formula
C24H29FN6
SMILES
CC(C)(C)CN1C2=C(C=CC(=N2)C3=C(N=C(N3)C(C)(C)C)C4=CC=C(C=C4)F)N=C1N
InChI
InChI=1S/C24H29FN6/c1-23(2,3)13-31-20-17(28-22(31)26)12-11-16(27-20)19-18(14-7-9-15(25)10-8-14)29-21(30-19)24(4,5)6/h7-12H,13H2,1-6H3,(H2,26,28)(H,29,30)
InChIKey
XPPBBJCBDOEXDN-UHFFFAOYSA-N
Compound name
5-[2-tert-butyl-4-(4-fluorophenyl)-1H-imidazol-5-yl]-3-(2,2-dimethylpropyl)imidazo[4,5-b]pyridin-2-amine
Related CIDs

2D Structure

compound 2d structure
3
Annotation Hits

30
References

991
Patents

420.24377 Da
Monoisotopic Mass

5.3
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 421.25105 210.4
[M+Na]+ 443.23299 220.8
[M-H]- 419.23649 214.2
[M+NH4]+ 438.27759 218.3
[M+K]+ 459.20693 212.3
[M+H-H2O]+ 403.24103 199.8
[M+HCOO]- 465.24197 223.1
[M+CH3COO]- 479.25762 218.2
[M+Na-2H]- 441.21844 209.7
[M]+ 420.24322 211.5
[M]- 420.24432 211.5
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

patents stripe